SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration
Competing interests CB: Honoraria from Alimera Sciences, Apellis, Bayer, and Roche; and has served on advisory boards for…